Cessation of nucleos(t)ide analogue therapy after HBEAG seroconversion is associated with a decreased chance of HBSAG loss in a Belgian, predominantly caucasion cohort of chronic hepatitis B patients

Acta Gastro-enterologica Belgica(2017)

引用 23|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要